U.S. health regulators are warning consumers not to use more than two dozen varieties of over-the-counter eyedrops because of the risk of infections that could lead to blindness.
The Food and Drug Administration advisory applies to lubricating drops sold by six companies, including CVS Health, Target, Rite Aid and Cardinal Health. Consumers should stop using the products immediately and avoid purchasing any that remain on pharmacy and store shelves, the FDA said in a statement Friday.
The agency asked the companies to recall their products last week, because FDA inspectors found unsanitary conditions and bacteria at the facility producing the drops. The FDA did not disclose the location of the factory or when it was inspected.
No injuries related to the products had been reported at the time of the announcement, but the FDA encouraged doctors and patients to submit cases through the agency’s online reporting system.
Earlier this year, federal officials linked an outbreak of drug-resistant bacteria to eyedrops from two companies, EzriCare and Delsam Pharma. More than 80 people in the U.S. tested positive for eye infections from the rare bacterial strain, according to the most recent update from the Centers for Disease Control and Prevention.
After the products were recalled in February, health inspectors visited the manufacturing plant in India that made the eyedrops and uncovered problems with how they were made and tested, including inadequate sterility measures.
The UN Intergovernmental Panel on Climate Change (IPCC) has released a new report providing multiple options for how the world can survive and adapt to climate change.
California Gov. Gavin Newsom over the weekend announced that the state has secured a contract with CIVCA to make $30 insulin available to all who need it. He also announced that the state will start manufacturing Naloxone, an emergency medication used to rapidly reverse the effects of an opioid overdose.
The global bottled water industry is booming, and it's coming at a steep environmental cost, according to the United Nations University Institute for Water, Environment and Health.
A new gel that helps stop bleeding for both emergency care and surgical procedures in animal medicine is being sought for FDA approval for a human version.
In this photo provided by Henry Danner, Omari Maynard sits with his children, Khari, left, and, Anari, holding a photo of their late mother, Shamony Gibson, at home in the Brooklyn borough of New York on April 9, 2022. Gibson passed away in 2019, two weeks after giving birth to Khari due to a pulmonary embolism. “She wasn’t being heard at all,” said Maynard, an artist who now does speaking engagements as a maternal health advocate.
The Environmental Protection Agency has proposed a new plan to lower the cap on the amount of harmful "forever chemicals" allowed in drinking water across the country.
